deferoxamine has been researched along with tricalcium phosphate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
de Vernejoul, MC; Guerin, AP; London, GM; Marchais, SJ; Marty, C; Metivier, F | 1 |
Barralet, JE; Drager, J; Gbureck, U; Harvey, EJ; Kumar, A; Ramirez-GarciaLuna, JL | 1 |
Wang, ZY; Wei, S; Zhang, RG | 1 |
3 other study(ies) available for deferoxamine and tricalcium phosphate
Article | Year |
---|---|
Arterial calcifications and bone histomorphometry in end-stage renal disease.
Topics: Aluminum; Bicarbonates; Bone and Bones; Bone Density; Calcium; Calcium Phosphates; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Lipid Metabolism; Male; Osteoblasts; Osteoclasts; Parathyroid Hormone; Renal Dialysis | 2004 |
Topics: Animals; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Deferoxamine; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Printing, Three-Dimensional; Rabbits; Ulna | 2017 |
Deferoxamine/magnesium modified β-tricalcium phosphate promotes the bone regeneration in osteoporotic rats.
Topics: Animals; Bone Regeneration; Calcium Phosphates; Cell Differentiation; Deferoxamine; Magnesium; Osteogenesis; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2022 |